| Literature DB >> 28212728 |
Eleonora Candi1, Artem Smirnov2, Emanuele Panatta2, Anna Maria Lena2, Flavia Novelli2, Mara Mancini3, Giuditta Viticchiè3, Maria Cristina Piro2, Nicola Di Daniele4, Margherita Annicchiarico-Petruzzelli5, Gerry Melino6.
Abstract
The transcription factor p63 belongs to the p53-family and is a master regulator of proliferative potential, lineage specification, and differentiation in epithelia during development and tissue homeostasis. In cancer, p63 contribution is isoform-specific, with both oncogenic and tumour suppressive roles attributed, for ΔNp63 and TAp63, respectively. Recently, p53 and TAp73, in line with other tumour suppressor genes, have emerged as important regulators of energy metabolism and metabolic reprogramming in cancer. To date, p63 contributions in controlling energy metabolism have been partially investigated; given the extensive interaction of the p53 family members, these studies have potential implications in tumour cells for metabolic reprogramming. Here, we review the role of p63 isoforms, TAp63 and ΔNp63, in controlling cell metabolism, focusing on their specific metabolic target genes and their physiological/functional context of action.Entities:
Keywords: Glycolysis; Metabolism; p53 family; p63
Mesh:
Substances:
Year: 2017 PMID: 28212728 DOI: 10.1016/j.bbrc.2016.10.094
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575